VJ7-31169-82011 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-11-18
Dose 1 — Pfizer-BioNTech
2021-12-11
Registered in v-safe
2021-12-11
Dose 2 — Pfizer-BioNTech
2021-12-11
Health check-in — day 0, dose 2, dependent
Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-12-13
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school

Adult check-in
2021-12-17
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · Headache, Nausea

Adult check-in
2021-12-18
Health check-in — day 7, dose 2, dependent
Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-12-25
Health check-in — day 14, dose 2, dependent
Feeling: Good

Adult check-in
2022-01-01
Health check-in — day 21, dose 2, dependent
Feeling: Fair

Adult check-in
2022-01-08
Survey response — day 28, dose 2, dependent
MedDRA: Fatigue — Feeling: Fair

Free text: Tired

MedDRA releases: 2024-11 · check-in free text available
2022-01-15
Health check-in — day 35, dose 2, dependent
Feeling: Good

Adult check-in
2022-01-22
Health check-in — day 42, dose 2, dependent
Feeling: Good

Adult check-in
2022-03-12
Health check-in — 3 months, dose 2, dependent
Feeling: Fair

Adult check-in
2022-06-11
Health check-in — 6 months, dose 2, dependent
Feeling: Good

Adult check-in
2022-12-11
Survey response — 12 months, dose 2, dependent
MedDRA: Asthma, Condition aggravated, Fatigue, Gastrointestinal pain, Nausea, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: (b)(6) has developed asthma, a reoccurrence Eosinophilic disease. He has been having serve GI pain. He's had more exhaustion, nausea GI pain.

MedDRA releases: 2024-11 · check-in free text available
2022-12-11
Report sent to call center — 12 months, dose 2, dependent
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-12-12
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-11-18	Pfizer-BioNTech	No
2	2021-12-11	Pfizer-BioNTech	No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 10 — day 28, dose 2, dependent

2022-01-08

Symptoms: Tired

Release 12 — 12 months, dose 2, dependent

2022-12-11

Symptoms: (b)(6) has developed asthma, a reoccurrence Eosinophilic disease. He has been having serve GI pain. He's had more exhaustion, nausea GI pain.

redacted (b)(6)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Asthma	·	·	✓
SD	Condition aggravated	·	·	✓
SD	Fatigue	·	·	✓
SD	Gastrointestinal pain	·	·	✓
SD	Nausea	·	·	✓
SD	Pre-existing disease	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release